Today: 9 June 2026
American Express stock barely budges after fresh loan data — what AXP investors are watching next
15 January 2026
2 mins read

American Express stock barely budges after fresh loan data — what AXP investors are watching next

NEW YORK, Jan 15, 2026, 2:13 PM ET — Regular session

  • American Express shares barely moved following the release of December card-loan delinquency and write-off figures in an SEC filing
  • U.S. consumer 30-day delinquencies declined, but small business late payments inched up
  • Attention turns to late-month earnings reports and ongoing Washington chatter about a proposed cap on credit card interest rates

Shares of American Express Company edged up roughly 0.1% to $358.54 on Thursday. The card issuer had just released fresh U.S. credit performance data, closely watched by investors as an early signal of potential loan losses.

The update comes at a tricky time for the card and payments sector. Traders are eyeing signs of credit stress after the holidays, even as chatter from Washington on credit-card pricing rattles a group that until recently behaved like a dependable compounder.

One policy risk on the horizon is President Donald Trump’s proposal to cap credit card interest rates at 10% for one year starting Jan. 20. JPMorgan Chief Financial Officer Jeremy Barnum slammed the plan as “very bad for consumers, very bad for the economy,” saying it would push lenders to tighten credit. Reuters

American Express unveiled preliminary delinquency and write-off figures for its U.S. Consumer card member loans held for investment in a Form 8-K filing covering the months ended Dec. 31, Nov. 30, and Oct. 31, 2025. Consumer loans stood at $100.2 billion as of Dec. 31. Loans 30 days past due dropped to 1.3% of the total, down from 1.4% in both November and October. The net write-off rate, representing the annualized pace of balances deemed uncollectible on a principal-only basis, remained steady at 2.1%.

U.S. small business card member loans hit $30.8 billion as of Dec. 31, with 30-day past due loans ticking up to 1.7% from 1.6% in both November and October. The net write-off rate held steady at 2.7% in December and November, slightly above October’s 2.6%. Combined U.S. consumer and small business loans held for investment stood at $131.0 billion.

The delinquency figure counts loans that are at least 30 days overdue. Write-offs reflect what the company has essentially written off as uncollectible, usually appearing later in provisions and earnings.

American Express isn’t a pure-play lender, yet credit costs remain crucial since they can squeeze margins if spending dips or delinquencies climb. That’s why these monthly updates draw interest, even when the stock barely budges.

Peers have faced similar scrutiny. Investors are using credit card issuers and card-heavy lenders as a barometer for the U.S. consumer’s condition—and recently, as casualties in the ongoing policy fights over rates and fees.

However, the risk is that the trend line could shift rapidly. Should small business delinquencies continue rising post-holidays, or if an interest-rate cap gains momentum, card economics might tighten, putting rewards at risk, warned several executives and analysts.

American Express is set to release its fourth-quarter and full-year earnings on Friday, Jan. 30, followed by a conference call at 8:30 a.m. ET. Investors will be focused on management’s outlook for spending trends, credit costs, and any insights related to ongoing policy discussions.

Stock Market Today

  • China Plans $295 Billion AI Data Center Network Amid Global Tech Stocks Drop
    June 9, 2026, 2:46 PM EDT. China is reportedly planning to invest around $295 billion over five years to establish a nationwide data center network dedicated to AI, aiming to reduce reliance on US technology by prioritizing domestic suppliers like Huawei. The initiative involves state-owned telecoms managing the infrastructure and seeks to unify fragmented data centers into a national system by 2028. This comes as chip stocks and major tech shares plunged, dragging down the Nasdaq and S&P 500 indexes. China's AI sector now includes over 6,200 companies with a market worth $177 billion. The plan may be funded through sovereign debt and state-backed funds, highlighting Beijing's strategic commitment to AI infrastructure despite slower economic growth.

Latest articles

Vanguard’s $1 Trillion VOO ETF Draws Investor Questions About the Road Ahead

Vanguard’s $1 Trillion VOO ETF Draws Investor Questions About the Road Ahead

9 June 2026
Vanguard’s S&P 500 ETF (VOO) became the first ETF to surpass $1 trillion in assets, drawing renewed scrutiny to low fees, index concentration, and valuation risks as tech stocks slid and VOO fell about 1% Tuesday, highlighting investor debate over sticking with S&P 500 trackers or shifting to broader funds like VTI.
AI chip ETF bulls hit with more losses as leveraged funds slide

AI chip ETF bulls hit with more losses as leveraged funds slide

9 June 2026
SOXL plunged 15.4% as leveraged semiconductor funds led tech’s sharp selloff, testing the narrow AI trade behind this year’s market gains; major chip stocks like AMD and Broadcom also tumbled, with investors eyeing Wednesday’s CPI data and the upcoming SpaceX listing as key risks for further volatility.
Bitcoin Hovers at $61,000 With CPI Report in Focus for Crypto Traders

Bitcoin Hovers at $61,000 With CPI Report in Focus for Crypto Traders

9 June 2026
Bitcoin slid to near $61,000, down 3%, as traders cut risk ahead of Wednesday’s U.S. inflation report, which is expected to show May CPI up 4.2% year-on-year—well above the Fed’s 2% target—keeping rate-hike risk in play and pressuring crypto and related stocks, with $5.8 billion in digital asset outflows reported in recent weeks.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop